Health Trials

JC Virus Infection

2

Review clinical trials related to JC Virus Infection. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus

This phase II trial studies how well donor cytotoxic T lymphocytes work in treating patients with malignancies with BK and/or JC virus. Cytotoxic T lymphocytes are made from donated blood cells that are grown in the laboratory and are designed to kill viruses that can cause infections in transplant patients and may be an effective treatment in patients with malignancies with BK and/or JC virus.

Participants needed: 100
Trial details
Phase: Phase 2Biological sex: AllType: InterventionalSponsor: M.D. Anderson Cancer CenterUpdated: Aug 21, 2026Locations: 1
Eligibility criteria

Patients ≥ 2 years. [+18]

Patients receiving > 6 mg / day of prednisone or equivalent at time of [+5]

Read more
Status: Available

TETRAVI Expanded Access Program

This Expanded Access Program (EAP) allows qualified physicians within Texas to obtain access to multivirus-specific cytotoxic T lymphocytes (VSTs) developed under Baylor College of Medicine's TETRAVI program (NCT04013802) for the treatment of persistent or recurrent infections with EBV, CMV, adenovirus, or BK virus in pediatric patients being treated in Texas who have received allogeneic stem cell transplants and have no other suitable therapeutic options.

Trial details
Age: Up to 17Biological sex: AllType: Expanded AccessSponsor: Baylor College of MedicineUpdated: Aug 5, 2025
Eligibility criteria

Patients <18 years of age. [+4]

Patients with active uncontrolled infections unrelated to the viruses mentioned. [+2]

Read more